Amarin | AMRN - Despesas Operacionais

Preço das Ações
14.31
Mudança Diária
-0.28 -1.92%
Mensal
-2.52%
Anual
37.20%
Q2 Previsão
13.88




Despesas Operacionais Alterar Data
AbbVie USD 10.81B 13.45B 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amarin USD 51.48M 113K 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
BioCryst Pharmaceuticals USD 146.17M 534.06M 2025-12
DBV Technologies USD 37.05M 4.06M 2025-09
Esperion Therapeutics USD 83.21M 14.06M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Neurocrine Biosciences USD 577.6M 22M 2025-12
Novartis USD 9.8B 61M 2025-12